# OnCo record new-epoc (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/new-epoc/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "new-epoc", "ISRCTN22944367" ;
  schema:name "New EPOC"@en ;
  schema:description "Adding the EGFR antibody around liver surgery shortened life by more than two years. It is the clearest warning in bowel cancer that a drug that helps in advanced disease can harm in the curative setting."@en ;
  schema:url <https://onco.cc/trials/new-epoc/> ;
  schema:dateModified "2026-09-24"^^xsd:date ;
  schema:citation <https://doi.org/10.1016/S1470-2045(19)30798-3>, <https://www.isrctn.com/ISRCTN22944367> ;
  onco:status "negative" ;
  onco:phase "3" ;
  onco:cancers <https://onco.cc/cancers/colorectal/> ;
  onco:technologies <https://onco.cc/technologies/monoclonal-antibody/>, <https://onco.cc/technologies/cytotoxic-chemotherapy/> ;
  onco:targets <https://onco.cc/targets/egfr/>, <https://onco.cc/targets/kras/> ;
  onco:drugs <https://onco.cc/drugs/cetuximab/>, <https://onco.cc/drugs/folfox/>, <https://onco.cc/drugs/capox/>, <https://onco.cc/drugs/oxaliplatin/> ;
  onco:institutions <https://onco.cc/institutions/birmingham-cancer-centre/> ;
  onco:terms <https://onco.cc/terms/hepatectomy/>, <https://onco.cc/terms/oligometastatic/> ;
  onco:trials <https://onco.cc/trials/eortc-40983/> .